JP2021502063A5 - - Google Patents

Download PDF

Info

Publication number
JP2021502063A5
JP2021502063A5 JP2020524000A JP2020524000A JP2021502063A5 JP 2021502063 A5 JP2021502063 A5 JP 2021502063A5 JP 2020524000 A JP2020524000 A JP 2020524000A JP 2020524000 A JP2020524000 A JP 2020524000A JP 2021502063 A5 JP2021502063 A5 JP 2021502063A5
Authority
JP
Japan
Prior art keywords
antigen
binding
chimeric protein
protein
binding chimeric
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2020524000A
Other languages
English (en)
Japanese (ja)
Other versions
JP2021502063A (ja
JP7760115B2 (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/EP2018/079891 external-priority patent/WO2019086548A1/en
Publication of JP2021502063A publication Critical patent/JP2021502063A/ja
Publication of JP2021502063A5 publication Critical patent/JP2021502063A5/ja
Priority to JP2023107875A priority Critical patent/JP2023138991A/ja
Application granted granted Critical
Publication of JP7760115B2 publication Critical patent/JP7760115B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2020524000A 2017-10-31 2018-10-31 新規抗原結合性キメラタンパク質とその方法及び使用 Active JP7760115B2 (ja)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP2023107875A JP2023138991A (ja) 2017-10-31 2023-06-30 新規抗原結合性キメラタンパク質とその方法及び使用

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
EP17199472.6 2017-10-31
EP17199472 2017-10-31
EP18199709 2018-10-10
EP18199709.9 2018-10-10
PCT/EP2018/079891 WO2019086548A1 (en) 2017-10-31 2018-10-31 Novel antigen-binding chimeric proteins and methods and uses thereof

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2023107875A Division JP2023138991A (ja) 2017-10-31 2023-06-30 新規抗原結合性キメラタンパク質とその方法及び使用

Publications (3)

Publication Number Publication Date
JP2021502063A JP2021502063A (ja) 2021-01-28
JP2021502063A5 true JP2021502063A5 (https=) 2021-09-24
JP7760115B2 JP7760115B2 (ja) 2025-10-27

Family

ID=64308706

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2020524000A Active JP7760115B2 (ja) 2017-10-31 2018-10-31 新規抗原結合性キメラタンパク質とその方法及び使用
JP2023107875A Withdrawn JP2023138991A (ja) 2017-10-31 2023-06-30 新規抗原結合性キメラタンパク質とその方法及び使用

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2023107875A Withdrawn JP2023138991A (ja) 2017-10-31 2023-06-30 新規抗原結合性キメラタンパク質とその方法及び使用

Country Status (7)

Country Link
US (2) US11873347B2 (https=)
EP (2) EP3704160B1 (https=)
JP (2) JP7760115B2 (https=)
KR (2) KR20200091400A (https=)
CN (1) CN111315784A (https=)
CA (1) CA3076791A1 (https=)
WO (1) WO2019086548A1 (https=)

Families Citing this family (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2020127993A1 (en) * 2018-12-21 2020-06-25 Vib Vzw Fusion protein with a toxin and scaffold protein
JP7627910B2 (ja) * 2018-12-21 2025-02-07 フエー・イー・ベー・フエー・ゼツト・ウエー サイトカイン及び足場タンパク質を含む融合タンパク質
EP3986437A4 (en) * 2019-06-18 2023-06-07 Musc Foundation for Research Development COMPOSITIONS TARGETED AGAINST THE NUCLEOTIDE-FREE STATE OF RAS AND METHODS FOR BLOCKING ONCOGENIC SIGNALING AND TRANSFORMATION
US20220378925A1 (en) * 2019-09-26 2022-12-01 Orionis Biosciences, Inc. Conjugated chimeric proteins
EP3799881A1 (en) 2019-10-04 2021-04-07 Max-Planck-Gesellschaft zur Förderung der Wissenschaften e.V. Single domain antibodies specifically binding globo - series glycans
CN110982824B (zh) * 2019-10-09 2022-04-15 天津大学 拮抗pd-1的抗体类似物bp基因及蛋白和应用
WO2021078786A1 (en) 2019-10-21 2021-04-29 Vib Vzw Nanodisc-specific antigen-binding chimeric proteins
US20240027467A1 (en) * 2019-12-20 2024-01-25 Vib Vzw Nanobody Exchange Chromatography
EP3845553A1 (en) * 2019-12-30 2021-07-07 Johann Wolfgang Goethe-Universität Carrier matrix comprising dodecin protein
JP7657406B2 (ja) * 2020-02-17 2025-04-07 国立大学法人大阪大学 膜タンパク質の結晶化方法及び膜タンパク質の構造解析方法
CN111518180B (zh) * 2020-04-10 2023-01-03 四川大学 一种结核病候选疫苗融合蛋白
US20230382977A1 (en) * 2020-09-24 2023-11-30 The Regents Of The University Of California Multimeric protein complexes as antibody substitutes for neutralization of viral pathogens in prophylactic and therapeutic applications
WO2022218928A1 (en) * 2021-04-12 2022-10-20 Saiba AG Modified virus-like particles of bacteriophage ap205
WO2022268993A1 (en) 2021-06-23 2022-12-29 Vib Vzw Means and methods for selection of specific binders
US12050189B2 (en) * 2021-09-10 2024-07-30 President And Fellows Of Harvard College Compositions and methods relating to structural determination of small proteins
EP4408461A1 (en) * 2021-09-30 2024-08-07 AdaptVac ApS Methods and particles for modulating an immune response
US20230368862A1 (en) * 2021-12-07 2023-11-16 The Trustees Of Columbia University In The City Of New York Binding site in type 2 ryanodine receptor
CN114540328A (zh) * 2022-02-18 2022-05-27 浙江工业大学 一种温度敏感型α-淀粉酶及其制备方法与应用
CN115819599B (zh) * 2022-11-29 2024-01-16 江苏耀海生物制药有限公司 一种利用重组大肠杆菌分泌表达纳米抗体Cablivi的方法
EP4474016A1 (en) 2023-06-07 2024-12-11 Julius-Maximilians-Universität Würzburg Strategies to target extracellularly accessible ras protein
EP4731770A1 (en) 2023-06-22 2026-04-29 Ablynx NV Chimeric proteins for modulating cytokine receptor activity
US20250084130A1 (en) * 2023-08-25 2025-03-13 Trustees Of Boston University Engineered mcp and pcp proteins and systems and methods thereof
WO2025061726A1 (en) * 2023-09-18 2025-03-27 John Innes Centre Vlp-scaffold based binding proteins
WO2025129010A1 (en) * 2023-12-14 2025-06-19 Genentech, Inc. Methods of structure determination using antibodies
WO2025172894A1 (en) 2024-02-16 2025-08-21 Glaxosmithkline Biologicals Sa Modified nanoparticle subunits and use thereof

Family Cites Families (47)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DD266710A3 (de) 1983-06-06 1989-04-12 Ve Forschungszentrum Biotechnologie Verfahren zur biotechnischen Herstellung van alkalischer Phosphatase
EP0368684B2 (en) 1988-11-11 2004-09-29 Medical Research Council Cloning immunoglobulin variable domain sequences.
DK1621554T4 (da) 1992-08-21 2012-12-17 Univ Bruxelles Immunoglobuliner blottet for lette kæder
ES2162863T3 (es) 1993-04-29 2002-01-16 Unilever Nv Produccion de anticuerpos o fragmentos (funcionalizados) de los mismos derivados de inmunoglobulinas de cadena pesada de camelidae.
FR2708622B1 (fr) 1993-08-02 1997-04-18 Raymond Hamers Vecteur recombinant contenant une séquence d'un gène de lipoprotéine de structure pour l'expression de séquences de nucléotides.
EP0739981A1 (en) 1995-04-25 1996-10-30 Vrije Universiteit Brussel Variable fragments of immunoglobulins - use for therapeutic or veterinary purposes
ES2294799T3 (es) 1996-06-27 2008-04-01 Vlaams Interuniversitair Instituut Voor Biotechnologie Vzw. Moleculas de anticuerpos que interactuan especificamente con el sitio activo o hendidura de una molecula diana.
AU3596599A (en) 1998-01-26 1999-08-09 Unilever Plc Method for producing antibody fragments
EP1141711A1 (en) 1999-01-05 2001-10-10 Unilever Plc Binding of antibody fragments to solid supports
DK1144616T4 (da) 1999-01-19 2009-03-30 Unilever Nv Fremgangsmåde til fremstilling af antistoffragmenter
CA2370351A1 (en) 1999-04-22 2000-11-02 Unilever Plc Inhibition of viral infection using monovalent antigen-binding proteins
US6479280B1 (en) 1999-09-24 2002-11-12 Vlaams Interuniversitair Institutuut Voor Biotechnologie Vzw Recombinant phages capable of entering host cells via specific interaction with an artificial receptor
WO2001040310A2 (en) 1999-11-29 2001-06-07 Unilever Plc Immobilisation of proteins using a polypeptide segment
ES2331051T3 (es) 1999-11-29 2009-12-21 Bac Ip B.V. Inmovilizacion de moleculas de union de antigenos de un dominio.
ES2324280T3 (es) 2000-03-14 2009-08-04 Unilever N.V. Dominios variables de la cadena pesada de anticuerpos frente a lipasas dieteticas humanas y sus usos.
US20030190598A1 (en) 2000-05-26 2003-10-09 Jasmid Tanha Single-domain antigen-binding antibody fragments derived from llama antibodies
ATE513854T1 (de) 2000-12-13 2011-07-15 Bac Ip B V Proteinraster aus variablen domänen der schweren immunoglobulinkette von kamelen
DK1399484T3 (da) 2001-06-28 2010-11-08 Domantis Ltd Dobbelt-specifik ligand og anvendelse af denne
US20060073141A1 (en) 2001-06-28 2006-04-06 Domantis Limited Compositions and methods for treating inflammatory disorders
JP4213586B2 (ja) 2001-09-13 2009-01-21 株式会社抗体研究所 ラクダ抗体ライブラリーの作製方法
JP2005289809A (ja) 2001-10-24 2005-10-20 Vlaams Interuniversitair Inst Voor Biotechnologie Vzw (Vib Vzw) 突然変異重鎖抗体
EP1456410A2 (en) 2001-12-11 2004-09-15 AlgoNomics N.V. Method for displaying loops from immunoglobulin domains in different contexts
EP1456237A2 (en) 2001-12-21 2004-09-15 Vlaams Interuniversitair Instituut voor Biotechnologie vzw. Method for cloning of variable domain sequences
CA2471645A1 (en) 2002-01-03 2003-07-10 Vlaams Interuniversitair Instituut Voor Biotechnologie Vzw Immunoconjugates useful for treatment of tumours
EP1558645B1 (en) 2002-11-08 2011-07-27 Ablynx N.V. Stabilized single domain antibodies in pharmaceutical composition adapted for inhalation
WO2004041863A2 (en) 2002-11-08 2004-05-21 Ablynx N.V. Single domain antibodies directed against interferon- gamma and uses therefor
MXPA05007151A (es) 2002-12-31 2005-09-21 Nektar Therapeutics Al Corp Polimeros terminados en maleimida hidroliticamente estables.
JP2006517789A (ja) 2003-01-10 2006-08-03 アブリンクス エン.ヴェー. 治療用ポリペプチド、その相同物、その断片、および血小板媒介凝集の調節での使用
US7461263B2 (en) 2003-01-23 2008-12-02 Unspam, Llc. Method and apparatus for a non-revealing do-not-contact list system
EP1656128A4 (en) 2003-08-12 2007-02-28 William M Yarbrough SINGLE ACNE TREATMENT AND METHOD OF USE
ATE485307T1 (de) 2003-11-07 2010-11-15 Ablynx Nv Camelidae schwere ketten antikörper vhhs gegen epidermalen wachstumfaktor rezeptor (egfr) und ihre verwendung
US7563443B2 (en) 2004-09-17 2009-07-21 Domantis Limited Monovalent anti-CD40L antibody polypeptides and compositions thereof
WO2006040153A2 (en) 2004-10-13 2006-04-20 Ablynx N.V. Single domain camelide anti -amyloid beta antibodies and polypeptides comprising the same for the treatment and diagnosis of degenarative neural diseases such as alzheimer's disease
AU2005325801A1 (en) 2005-01-31 2006-08-03 Ablynx N.V. Method for generating variable domain sequences of heavy chain antibodies
US8188223B2 (en) 2005-05-18 2012-05-29 Ablynx N.V. Serum albumin binding proteins
ES2694247T3 (es) 2005-05-20 2018-12-19 Ablynx N.V. NanobodiesTM mejorados para el tratamiento de trastornos mediados por agregación
WO2008020079A1 (en) 2006-08-18 2008-02-21 Ablynx N.V. Amino acid sequences directed against il-6r and polypeptides comprising the same for the treatment of deseases and disorders associated with il-6-mediated signalling
EP2121757A2 (en) 2007-02-21 2009-11-25 Ablynx N.V. Amino acid sequences directed against vascular endothelial growth factor and polypeptides comprising the same for the treatment of conditions and diseases characterized by excessive and/or pathological angiogenesis or neovascularization
CA2687903C (en) 2007-05-24 2016-09-13 Ablynx N.V. Amino acid sequences directed against rank-l and polypeptides comprising the same for the treatment of bone diseases and disorders
GB201008682D0 (en) 2010-05-25 2010-07-07 Vib Vzw Epitope tag for affinity based applications
GB201014715D0 (en) 2010-09-06 2010-10-20 Vib Vzw Nanobodies stabilizing functional conformational states of GPCRS
SG10201805064SA (en) 2011-06-23 2018-07-30 Ablynx Nv Techniques for predicting, detecting and reducing aspecific protein interference in assays involving immunoglobulin single variable domains
NO2723764T3 (https=) * 2011-09-15 2018-05-26
CN105102478A (zh) * 2013-01-30 2015-11-25 弗拉芒区生物技术研究所 用于筛选和药物发现目的的新型嵌合多肽
US20150368339A1 (en) 2013-02-05 2015-12-24 Vib Vzw Muscarinic acetylcholine receptor binding agents and uses thereof
PL3097197T3 (pl) 2014-01-21 2021-06-28 Vrije Universiteit Brussel Mięśniowo-specyficzne elementy regulatorowe kwasów nukleinowych oraz sposoby i ich zastosowanie
EP4707303A2 (en) 2014-05-16 2026-03-11 Ablynx NV Improved immunoglobulin variable domains

Similar Documents

Publication Publication Date Title
JP2021502063A5 (https=)
JP7273135B2 (ja) 交差結合領域の配向性を有する二重可変領域抗体様結合タンパク質
US20240174767A1 (en) Novel Antigen-Binding Chimeric Proteins and Methods and Uses Thereof
JP2020023523A5 (https=)
JP2021531826A5 (https=)
US20160280791A1 (en) Dual variable domain immunoglobulins and uses thereof
JP7173964B2 (ja) 抗p53抗体
JP2016516049A5 (https=)
JP2013537416A5 (https=)
JP2014158485A5 (https=)
JP2016521683A5 (https=)
Jevševar et al. PEGylation of antibody fragments for half-life extension
TW201333035A (zh) 針對il-13及/或il-17之雙特異性結合蛋白
TW202108613A (zh) 用於多聚化蛋白質及其分離的變異區域
JP2023544211A (ja) Sars-cov-2を標的とするポリペプチドならびに関連する組成物および方法
Silva-Pilipich et al. A small virus to deliver small antibodies: new targeted therapies based on AAV delivery of nanobodies
JP2015512247A5 (https=)
Huang et al. A novel efficient bispecific antibody format, combining a conventional antigen-binding fragment with a single domain antibody, avoids potential heavy-light chain mis-pairing
Lee et al. Affinity maturation of a T-cell receptor-like antibody specific for a cytomegalovirus pp65-derived peptide presented by HLA-A* 02: 01
Cornish et al. Structural and functional characterization of nanobodies that neutralize Omicron variants of SARS-CoV-2
CN120659804A (zh) 多价蛋白质及筛选方法
Xu et al. Screening of random peptide library of hemagglutinin from pandemic 2009 A (H1N1) influenza virus reveals unexpected antigenically important regions
JP2018500879A5 (https=)
TWI918721B (zh) Egfr結合複合物及其製備和使用方法
JP2026513849A (ja) Pdgfrアルファを発現するがんを画像診断するための試薬及び方法